Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice

Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation

David L. Lacey, Emma Timms, Hong‐Lin Tan et al. · Cell · 1998 · 5.4K citations · Full text

Inflammation, Osteoprotegerin Ligand, Sclerostin +13

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Hisataka Yasuda, Nobuyuki Shima, N. Nakagawa et al. · Proceedings of the National Academy of Sciences · 1998 · 4.2K citations · Full text

Osteoprotegerin/osteoclastogenesis-inhibitory Factor, Sclerostin, Tumor Microenvironment +14

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

Young‐Yun Kong, Hiroki Yoshida, Ildiko Sarosi et al. · Nature · 1999 · 3.3K citations

Developmental Biology, Key Regulator, Bone Morphogenic Protein +11

Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

Hiroshi Takayanagi, Sunhwa Kim, Takako Koga et al. · Developmental Cell · 2002 · 2.6K citations · Full text

Terminal Differentiation, Integrate Rankl Signaling, Developmental Biology +11

RANK is essential for osteoclast and lymph node development

William C. Dougall, Moira Glaccum, K Charrier et al. · Genes & Development · 1999 · 1.5K citations · Full text

Inflammation, Cytokine, Developmental Biology +15